Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Rebus Biosystems
AddedFeb 17, 2024
UpdatedJun 18, 2026
Rebus Biosystems

Rebus Biosystems

Series B

Rebus Biosystems: Providing uncompromised spatial omics with customizable assays and subcellular resolution.

HQ
Santa Clara, CA, US
Founded
2006
Overview
Compare
Fundraising
Employees
Website

At Rebus Biosystems, our vision is spatial omics without compromise. Get subcellular resolution of biological molecules directly in and across large tissue sections.

Customizable assays allow you to focus on the targets that matter most to your research. Available as a fully automated, integrated instrument for your lab in early 2021. Get access now available through our Spatial Omics as a Service program.

Rebus Biosystems - Similar Companies

Spatial Genomics logo

Spatial Genomics

AtlasXomics logo

AtlasXomics

atlasxomics.com

Akoya Biosciences logo

Akoya Biosciences

akoyabio.com

10x Genomics logo

10x Genomics

10xgenomics.com

Vizgen logo

Vizgen

vizgen.com

Syncell logo

Syncell

syncell.com

Stellaromics logo

Stellaromics

stellaromics.com

Singular Genomics logo

Singular Genomics

Cellanome logo

Cellanome

cellanome.com

RareCyte logo

RareCyte

rarecyte.com

S2 Genomics logo

S2 Genomics

s2genomics.com

BioSkryb Genomics logo

BioSkryb Genomics

bioskryb.com

Mission Bio logo

Mission Bio

CasTag Biosciences logo

CasTag Biosciences

Pacific Biosciences of California logo

Pacific Biosciences of California

Rebus Biosystems - Quick Facts

Who are Rebus Biosystems' competitors?

Companies similar to Rebus Biosystems include Spatial Genomics, AtlasXomics, Akoya Biosciences and 10x Genomics.

When was Rebus Biosystems founded?

Rebus Biosystems was founded in 2006.

Where is Rebus Biosystems' headquarters located?

Rebus Biosystems' headquarters is located in Santa Clara, CA, US.

When was Rebus Biosystems' last funding round?

Rebus Biosystems' most recent funding round was for $17.8M (USD) in November 2022.

How much has Rebus Biosystems raised to-date?

As of Nov 3, 2022, Rebus Biosystems has raised a total of $37.8M (USD).

How many employees does Rebus Biosystems have?

Rebus Biosystems has 14 employees as of Feb 5, 2024.

Rebus Biosystems - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Analytics
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Transactional
Customer
  • Enterprise
Main Product
  • Assays
  • Spatial Omics
Tags
  • Biotech
  • Data
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified